Clinical trial
The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power…
NCT00467896 · Actelion, Industry · Terminated
Key facts
| NCT number | NCT00467896 |
|---|---|
| Title | The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting |
| Official title | A Comparison of Safety and Inhalation Times of Ventavis (Iloprost) Inhalation Solution Delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study" |
| Lead sponsor | Actelion, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost PD-6, Iloprost PD-15 |
| Enrollment | 62 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2010 |
| Completion | Jun 1, 2011 |
| First posted | May 1, 2007 |
| Last update posted | Apr 4, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: